Theophylline disposition--effects of cimetidine, mebendazole and albendazole.
On the basis of the report that benzimidazoles bind to and inhibit the hepatic cytochrome P-450 enzyme system, the effect of mebendazole and albendazole on theophylline disposition was studied in 12 volunteers. Mebendazole at a dose of 100 mg b.d. for 3 days did not significantly alter the theophylline half-life, volume of distribution or clearance in a group of six. In another group of six adult volunteers, albendazole (400 mg) pretreatment did not alter the same parameters. However, in this second group, pretreatment with cimetidine (400 mg t.d.s. for 5 days) significantly increased theophylline half life from 7.7 to 9.8 +/- 1.5 h (P less than 0.001) and reduced its clearance from 0.8 to 0.60 +/- 0.1 ml min-1 kg-1 (P less than 0.005). The volume of distribution was not altered significantly. It is concluded that at therapeutic doses it is unlikely that mebendazole or albendazole will induce theophylline toxicity if co-administered with the bronchodilator. Cimetidine-induced impairment of theophylline metabolism is such that toxicity will be more likely in individuals with initial high theophylline clearance.
Adebayo
G I
GI
Department of Pharmacology, College of Medicine, Lagos, Nigeria.
Mabadeje
A F
AF
D000293:Adolescent; D000328:Adult; D015766:Albendazole / Q000494:pharmacology*; D002927:Cimetidine / Q000494:pharmacology*; D004347:Drug Interactions; D006801:Humans; D008297:Male; D008463:Mebendazole / Q000494:pharmacology*; D013806:Theophylline / Q000493:pharmacokinetics*
D002927:Cimetidine; D008463:Mebendazole; D013806:Theophylline; D015766:Albendazole